Management Team

CEO

Dave Tapolczay Chief Executive
Officer
Contact Dave

Dave is MRC Technology’s CEO. He has 28 years experience in R&D management and has been involved in the start-up of five companies, all of which are still trading.

Human Resources

Amanda Cowley Associate Director
Human Resources
Contact Amanda

As the Head of HR,  Amanda  is responsible for leading the people agenda within MRCT.

Governance & Licensing

Edward Bliss General Counsel &
Company Secretary
Contact Edward

General Counsel and Company Secretary. Edward also manages our Licensing team.

Drug Discovery

Justin Bryans Director, Drug
Discovery
Contact Justin

Justin runs our drug discovery and antibody engineering groups at the Centre for Therapeutics Discovery who work on small molecule and antibody projects.

Centre for Diagnostic Development

Michael Dalrymple Director, Centre
for Diagnostics
Development
Contact Michael

Mike heads up the Centre for Diagnostics Development (CDD), MRCT’s translational activity seeking to develop novel diagnostic tests from cutting edge basic research. In addition, Mike is leading the creation of a scientific foresighting function at MRCT to identify future charitable investment areas in translation and runs a small scientific due diligence team that assists the company in new project assessment and acquisition.

BUSINESS DEVELOPMENT

Mike Johnson Business
Development Director
Contact Mike

Mike leads our Business Development and Marketing teams.  He is responsible for accessing projects to fill our drug discovery pipeline, licensing them out to industry partners and creating new models to deliver patient impact.

Technology Transfer

Andrew Farquharson Director,
Technology Transfer
Contact Andrew

Andrew leads the team responsible for identifying, protecting and progressing promising life science research to improve human health.

Finance

Andrew Mercieca Director,
Finance
Contact Andrew

Andrew manages our Finance department, and also oversees our ICT service

Key Contacts

Business Development

John Kelly Associate Director,
Business Development
Contact John

John heads a team responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.

Drug Discovery

Katy Kettleborough Associate Director,
Biology
Contact Katy

Katy is an Associate Director in MRC Technology’s Centre for Therapeutics Discovery. She manages a team of biologists carrying out assay development and screening.

David Matthews

Drug Discovery

David Matthews Associate Director
BioTherapeutics
Contact David

David heads up MRC Technology’s BioTherapeutics team. The group develops therapeutic antibodies, this includes antibody generation, humanisation, affinity maturation and biophysical characterisation of candidates.

Drug Discovery

Andy Merritt Associate Director,
Chemistry
Contact Andy

Andy manages a team of medicinal chemists who carry out early stage drug discovery, including hit-to-lead development at our Centre for Therapeutics Discovery

Jonathan McGee

Marketing

Jonathan McGee Head of Marketing
& Communications
Contact Jonathan

Jonathan leads our marketing and communications team to enable mutually beneficial relationships between MRC Technology and its customers.

Innovation and Initiatives

David Pardoe Associate Director Contact David

Dave is responsible for creating and implementing novel collaborative models across charity, industry, funder and academic partners that accelerate new therapies to patients.

PR & Communications

Liezel Tipper PR & Communications
Manager
Contact Liezel

Liezel manages media relations, internal and external communications.

Business Development

Business Development

Kevin Buchan Business Development
Manager
Contact Kevin

Kevin is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.

Business Development

Derek Sheader Business Development
Manager
Contact Derek

Derek is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.

Business Development

Meera Swami Business Development
Manager
Contact Meera

Meera is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.

Business Development

Zhi Zhang Business Development
Manager
Contact Zhi

Zhang is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry, particularly in China.

Identifying, protecting, developing and licensing research

Technology Transfer

Mike Bond Business Manager Contact Mike

Mike covers LMB PNAC (shared), LMB Neurobiology (shared), Gambia, Uganda and CTSU.

Technology Transfer

Rachael Brooker Business Manager Contact Rachael

Rachael covers LMB PNAC (shared) and IGMM – ECRC.

Technology Transfer

Antonia Chatzopoulou Business Manager Contact Antonia

Antonia is responsible for the MRC Institute of Hearing Research, the MRC Cognition & Brain Sciences Unit, the MRC Biostatistics Unit and the MRC Human Nutrition Research unit (shared).

Technology Transfer

Sam Goldsmith Business Manager Contact Sam

Sam covers LMB Neurobiology Division, Mammalian Genetics Unit,  Mary Lyons Centre (MRC Harwell).

Technology Transfer

Madhu Madhusudhan Charity Sector
Business Manager
Contact Madhu

Madhu looks after IP issues for our charity partners

Technology Transfer

Anji Miller Senior Business
Manager
Contact Anji

Anji manages all IP, contractual and technology transfer matters arising from the MRC Prion Unit.

Technology Transfer

Alex Templar Business Manager Contact Alex

Alex covers LMB Protein and Nucleic Acid Chemistry Division, MRC Molecular Haematology Unit and MRC Human Immunology Units at MRC WIMM.